These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 22687730)

  • 61. A hierarchical screening methodology for physicochemical/ADME/Tox profiling.
    DeWitte RS; Robins RH
    Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):805-17. PubMed ID: 17014396
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The impact of assay technology as applied to safety assessment in reducing compound attrition in drug discovery.
    Thomas CE; Will Y
    Expert Opin Drug Discov; 2012 Feb; 7(2):109-22. PubMed ID: 22468913
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Drug discovery-background and foreground.
    Tishler M
    Clin Pharmacol Ther; 1973; 14(4):479-86. PubMed ID: 4723254
    [No Abstract]   [Full Text] [Related]  

  • 64. [Expectations for the education of graduate school of pharmaceutical sciences from the viewpoint of discovery and development of new drugs].
    Ohmori K
    Yakugaku Zasshi; 2011; 131(6):939-43. PubMed ID: 21628982
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Metabonomics techniques and applications to pharmaceutical research & development.
    Lindon JC; Holmes E; Nicholson JK
    Pharm Res; 2006 Jun; 23(6):1075-88. PubMed ID: 16715371
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A Survey of Neonatal Pharmacokinetic and Pharmacodynamic Studies in Pediatric Drug Development.
    Wang J; Avant D; Green D; Seo S; Fisher J; Mulberg AE; McCune SK; Burckart GJ
    Clin Pharmacol Ther; 2015 Sep; 98(3):328-35. PubMed ID: 25975723
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Trends in Modern Drug Discovery.
    Eder J; Herrling PL
    Handb Exp Pharmacol; 2016; 232():3-22. PubMed ID: 26330257
    [TBL] [Abstract][Full Text] [Related]  

  • 68. What will be the role of pharmacogenetics in evaluating drug safety and minimising adverse effects?
    Ozdemir V; Shear NH; Kalow W
    Drug Saf; 2001; 24(2):75-85. PubMed ID: 11235820
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cytochrome P450s and other enzymes in drug metabolism and toxicity.
    Guengerich FP
    AAPS J; 2006 Mar; 8(1):E101-11. PubMed ID: 16584116
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Systems pharmacology in drug discovery and therapeutic insight for herbal medicines.
    Huang C; Zheng C; Li Y; Wang Y; Lu A; Yang L
    Brief Bioinform; 2014 Sep; 15(5):710-33. PubMed ID: 23736100
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Potential functional and pathological side effects related to off-target pharmacological activity.
    Lynch JJ; Van Vleet TR; Mittelstadt SW; Blomme EAG
    J Pharmacol Toxicol Methods; 2017 Sep; 87():108-126. PubMed ID: 28216264
    [TBL] [Abstract][Full Text] [Related]  

  • 72. In silico ADME-Tox modeling: progress and prospects.
    Alqahtani S
    Expert Opin Drug Metab Toxicol; 2017 Nov; 13(11):1147-1158. PubMed ID: 28988506
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Regulatory authorities expect innovative drug delivery systems (DDS)].
    Mori K
    Yakugaku Zasshi; 2013; 133(1):73-80. PubMed ID: 23292023
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Addressing Translational Research in Efficacy and Safety of New Medicines. Abstracts of the 2006 International Conference Frontiers of Pharmacology and Toxicology, August 28-31, 2006, Chicago, Illinois, USA.
    Chem Biol Interact; 2006 Jul; 161(3):177-226. PubMed ID: 16977696
    [No Abstract]   [Full Text] [Related]  

  • 75. The pivotal role of drug metabolism and pharmacokinetics in the discovery and development of new medicines.
    Alavijeh MS; Palmer AM
    IDrugs; 2004 Aug; 7(8):755-63. PubMed ID: 15334309
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Application of efficient synthetic techniques in drug research].
    Zhou Y; Zhang L; Li Z; Liu H
    Yao Xue Xue Bao; 2013 Jul; 48(7):1014-30. PubMed ID: 24133968
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Application of toxicogenomic tools in the drug research and development process.
    Fabre N; Anglade I; Vericat JA
    Toxicol Lett; 2009 Apr; 186(1):13-7. PubMed ID: 19373985
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Principles of early drug discovery.
    Hughes JP; Rees S; Kalindjian SB; Philpott KL
    Br J Pharmacol; 2011 Mar; 162(6):1239-49. PubMed ID: 21091654
    [TBL] [Abstract][Full Text] [Related]  

  • 79. European initiative towards quality standards in education and training for discovery, development and use of medicines.
    Klech H; Brooksbank C; Price S; Verpillat P; Bühler FR; Dubois D; Haider N; Johnson C; Lindén HH; Payton T; Renn O; See W
    Eur J Pharm Sci; 2012 Apr; 45(5):515-20. PubMed ID: 22178534
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Using quantitative systems pharmacology for novel drug discovery.
    Pérez-Nueno VI
    Expert Opin Drug Discov; 2015 Dec; 10(12):1315-31. PubMed ID: 26328768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.